A Member of the University of Maryland Medical System   |   In Partnership with the University of Maryland School of Medicine

Share

Email PageEmail Print PagePrint

Home > Medical Reference > Complementary Medicine

 

Disclaimer

Note: The resources listed in this guide are not intended to be fully systematic or complete, nor does inclusion here imply any endorsement or recommendation by The University of Maryland or the Center for Integrative Medicine. The University of Maryland and the Center for Integrative Medicine make no warranties, express or implied, about the value or utility for any purpose of the information and resources contained herein.

Related Content


 

Raynaud's phenomenon

Introduction:

Raynaud's phenomenon, also called Raynaud's syndrome or disease, is a condition where blood vessels in the fingers and toes (and sometimes in the earlobes, nose, and lips) narrow and cause the skin to turn a pale or a patchy red to blue. The affected body part may feel numb and cold. It is usually triggered by cold or stress. Episodes come and go and may last minutes or hours. Women are five times more likely to have Raynaud' s than men. It usually occurs between the ages of 20 - 40 in women and later in life in men. It can exist by itself (primary Raynaud's) or as a result of other conditions (such as scleroderma, lupus, and rheumatoid arthritis). If it exists because of an underlying condition, it is called secondary Raynaud' s. Although some cases may be severe, very often Raynaud' s does not cause permanent damage.

Signs and Symptoms:

  • Changes in skin color in the fingers or toes and sometimes in the nose, legs, or earlobes (may occur in three phases: white, blue, then red)
  • Throbbing, tingling, numbness, and pain
  • Deterioration of the pads on fingertips or toes (rare; in severe cases)
  • Gangrenous ulcers near fingertips (rare; in severe cases)

What Causes It?:

No one knows what causes primary Raynaud's. Researchers think that when people with Raynaud' s get cold or feel stress -- which causes blood vessels to narrow -- their blood vessels overreact and constrict more than they do in people without Raynaud' s. Primary Raynaud' s is more common in people who live in cold climates and among people who also have a relative with Raynaud' s. Risk factors for secondary Raynaud' s include:

  • Cigarette smoking
  • Age in women (Raynaud' s tends to occur between the ages of 20 - 40, although secondary Raynaud' s tends to occur later)
  • Occupation (for example, using vibrating tools such as chain saws and jackhammers)
  • Using some medications, including some cancer drugs, narcotics, and over-the-counter cold medications
  • Previous frostbite
  • Repetitive physical stress (for example, typing or playing the piano)
  • Carpal tunnel syndrome
  • Other medical conditions, such as rheumatoid arthritis, scleroderma, systemic lupus erythematosus (SLE or lupus), and carpal tunnel syndrome. If you have Raynaud' s because of these conditions, it is called secondary Raynaud's and is often more severe.

What to Expect at Your Provider's Office:

Your doctor may do a cold simulation test where you are exposed to cold air or water to see if it brings on symptoms of Raynaud' s. Your doctor may also look at the base of your fingernail under a microscope to help determine if there is an underlying condition. If your doctor suspects there may be an underlying condition, he may do several blood tests, such as the antinuclear antibody test and the erythrocyte sedimentation rate (ESR), to look for connective tissue disease or other autoimmune disorders. If you have primary Raynaud's phenomenon, your health care provider may suggest trying to manage it with self-care strategies (for example, dressing warmly, avoiding the cold, controlling stress).

Treatment Options:

Many times you can help prevent symptoms of Raynaud' s. One of the most important things you can do is to stop smoking. Nicotine shrinks arteries and decreases blood flow. Other ways you can help prevent symptoms include:

  • Protecting yourself from cold, especially outdoors in the winter
  • Guarding against cuts and other injuries to affected areas
  • Avoiding caffeine
  • Avoiding stress
  • Exercising to increase circulation

Often, this may be enough to manage Raynaud's phenomenon.

Drug Therapies

Several types of drugs are used to treat Raynaud's phenomenon.

  • Calcium-channel blockers -- may reduce the frequency and severity of attacks. These drugs include:
    • Nifedipine (Procardia)
    • Amlodipine (Norvasc)
    • Verapamil (Calan, Isoptin)
    • Diltiazem (Cardizem)
    • Felodipine (Plendil)
    • Nisoldipine (Sular)
    • Bepridil (Vascor)
  • Alpha blockers -- help counteract the effects of norepinephrine, a hormone produced by the body that causes blood vessels to narrow. Alpha blockers include:
    • Prazosin (Minipress)
    • Doxazosin (Cardura)
  • Vasodilators -- open up blood vessels.

Surgical Procedures

In severe cases, a surgical procedure called sympathectomy, which cuts the nerves that open and close blood vessels, may be used.

Complementary and Alternative Therapies

Be sure to let all your doctors know about any herbs, supplements, or alternative therapies you are using. Some complementary and alternative medicine (CAM) therapies can interfere with conventional medical therapies. Work with a doctor who is experienced in CAM therapies to find the right mix of treatments for you.

Nutrition

Avoid caffeine and alcohol, and get regular exercise. These supplements may help:

  • Omega-3 fatty acids, found in fish oil (1,500 mg two to three times per day), may reduce symptoms in people with primary Raynaud's, according to one study. Fish oil did not reduce symptoms in people who had secondary Raynaud' s. High doses of fish oil can increase your risk of bleeding, so ask your doctor before taking it -- especially if you already take blood-thinning medication.
  • Evening primrose oil (EPO, 3 to 6 g per day) contains a different type of fatty acid that stops the body from making chemicals that narrow blood vessels. In one study, people with Raynaud' s who took EPO reduced the frequency and severity of attacks compared to those who took placebo. More research is needed, however. People who have a history of seizures should not take EPO. EPO can increase your risk of bleeding, so ask your doctor before taking it -- especially if you already take blood-thinning medication.
  • Inositol hexaniacinate, a form of vitamin B3 or niacin, may reduce frequency of Raynaud's attacks. In studies, people took high doses of inositol hexaniacinate, which can be dangerous if not monitored by a doctor. If you want to try inositol hexaniacinate, ask your doctor to determine the right dose for you.
  • Magnesium (200 mg three times per day) dilates blood vessels. Some doctors suggest taking a magnesium supplement, although there are no scientific studies to see whether it works. Take with meals and reduce dose if diarrhea occurs.

Herbs

Herbs are generally a safe way to strengthen and tone the body's systems. As with any therapy, you should work with your health care provider to diagnose your problem before starting any treatment. You may use herbs as dried extracts (capsules, powders, teas), glycerites (glycerine extracts), or tinctures (alcohol extracts). Unless otherwise indicated, make teas with 1 tsp. herb per cup of hot water. Steep covered 5 - 10 minutes for leaf or flowers, and 10 - 20 minutes for roots. Drink 2 - 4 cups per day. You may use tinctures alone or in combination as noted.

Tell your doctor if you are pregnant or nursing before using any herbal products.

Ginkgo (Ginkgo biloba) 120 - 160 mg per day -- can dilate blood vessels and increase circulation in the fingers. One preliminary study found that people with Raynuad' s who took 160 mg of ginkgo per day has less pain. Talk to your health care provider before taking ginkgo. Ginkgo can interact with several herbs and medications, and can increase your risk of bleeding, especially if you take blood thinning medications.

Homeopathy

Homeopathy may be useful as a supportive therapy.

Acupuncture

Although no major studies have looked at the effectiveness of acupuncture in treating Raynaud's syndrome, some people may find that acupuncture increases blood flow and decreases pain.

Mind-Body Medicine

Although there have not yet been any clinical trials, there are some anecdotal reports that people with Raynaud's have used guided imagery to reduce symptoms. More research is needed.

Following Up:

Most cases of Raynaud' s are not severe. Symptoms can be controlled by avoiding cold and stress, and not smoking.

Special Considerations:

Many drugs used to treat Raynaud's phenomenon may cause birth defects, so pregnant women should not use them. Some people with Raynaud' s also have depression, so talk to your doctor if you experience feelings of sadness or other symptoms of depression. Some people with Raynaud' s also have migraines.

These medications should be avoided if you have Raynaud' s, because they can make symptoms worse. Ask your doctor about the safest way to stop taking these medications or what substitutes might work better for you. Do not stop taking prescription medications without first talking to your doctor:

  • Some over-the-counter cold and flu drugs -- Avoid drugs that contain pseudoephedrine, such as Actifed, Chlor-Trimeton, and Sudafed.
  • Beta-blockers -- used to treat high blood pressure and heart disease. They include:
    • Acebutolol (Sectral)
    • Atenolol (Tenormin)
    • Bisoprolol (Zebeta)
    • Carteolol (Cartrol)
    • Metoprolol (Lopressor, Toprol XL)
    • Nadolol (Corgard)
    • Propranolol (Inderal)
  • Birth control pills
  • Reviewed last on: 3/7/2010
  • Steven D. Ehrlich, NMD, Solutions Acupuncture, a private practice specializing in complementary and alternative medicine, Phoenix, AZ. Review provided by VeriMed Healthcare Network.

Supporting Research

Batchelder HJ. Allopathic specific condition review: Raynaud's disease. Protocol J Botan Med. 1996;2:134-137.

Belch JJ, Shaw B, O'Dowd A, et al. Evening primrose oil (Efamol) as a treatment for cold-induced vasospasm (Raynaud's phenomenon). Prog Lipid Res. 1986;25:335-340.

Beretta L, Astori S, Ferrario E, Caronni M, Raimondi M, Scorza R. Determinants of depression in 111 Italian patients with systemic sclerosis. Reumatismo. 2006;58(3):219-25.

Choi WS, Choi CJ, Kim KS, Lee JH, Song CH, Chung JH, Ock SM, Lee JB, Kim CM. To compare the efficacy and safety of nifedipine sustained release with Ginkgo biloba extract to treat patients with primary Raynaud's phenomenon in South Korea; Korean Raynaud study (KOARA study). Clin Rheumatol. 2009 May;28(5):553-9.

DiGiacomo RA, Kremer JM, Shah DM. Fish-oil dietary supplementation in patients with Raynaud's phenomenon: a double-blind, controlled, prospective study Am J Med 1989;86:158-64

Fries R, Shariat K, von Wilmowsky H, Bohm M. Sildenafil in the treatment of Raynaud's phenomenon resistant to vasodilatory therapy. Circulation. 2005;112:2980-2985.

Herrick AL. Pathogenesis of Raynaud's phenomenon. Rheumatology. 2005;44(5):587-96.

Malenfant D, Catton M, Pope JE. The efficacy of complementary and alternative medicine in the treatment of Raynaud's phenomenon: a literature review and meta-analysis. Rheumatology (Oxford). 2009 Jul;48(7):791-5.

Mitchell W, Batchelder HJ. Naturopathic specific condition review: Raynaud's disease. Protocol J Botan Med. 1996;2:138-140.

Muir AH, Robb R, McLaren M, et al. The use of Ginkgo biloba in Raynaud's disease: a double-blind placebo-controlled trial.Vasc Med. 2002;7:265-7.

Salsano F, Letizia C, Proietti M, Rossi C, Proietti AR, Rosato E, Pisarri S. Significant changes of peripheral perfusion and plasma adrenomedullin levels in N-acetylcysteine long term treatment of patients with sclerodermic Raynaud's phenomenon. Int J Immunopathol Pharmacol. 2005;18(4):761-70.

Sunderkotter C, Riemekasten G. Pathophysiology and clinical consequences of Raynaud's phenomenon related to systemic sclerosis. Rheumatology. 2006;45(Supple):iii33-iii35.

Sunderland, GT, Belch JJ, Sturrock RD, et al. A double-blind randomised placebo-controlled trial of hexopal in primary Raynaud's disease. Clin Rheumatol. 1988;7:46-49.

Thompson AE, Pope JE. Calcium channel blockers for primary Raynaud's phenomenon: A meta-analysis. Rheumatololgy. 2005;44(2):145-50.

Adam QualityA.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is an independent audit to verify that A.D.A.M. follows rigorous standards of quality and accountability. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial policy, editorial process and privacy policy. A.D.A.M. is also a founding member of Hi-Ethics and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed medical professional should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. © 1997- A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.
adam.com
Connect with UMMC
Facebook Twitter YouTube Blog iPhone

Please rate the quality of this article.

Do you find this article to be helpful / informative?
              
Poor                                       Excellent

Do you have any brief comments on this page: (up to 255 characters)

© 2011 University of Maryland Medical Center (UMMC). All rights reserved.
UMMC is a member of the University of Maryland Medical System,
22 S. Greene Street, Baltimore, MD 21201. TDD: 1-800-735-2258 or 1.866.408.6885